文献速递肿瘤 PET/CT

双时间点18F-FDG PET/CT用于食管癌分期:滞留指数对非钙化淋巴结N分期诊断效能最佳

Dual-time point 18F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2018-03-03

研究纳入35例食管鳞状细胞癌手术患者为测试集、19例为验证集,评估双时间点18F-FDG PET/CT(60和120分钟)在分期中的作用。测试集中RImax以6%为最佳截断值诊断转移性淋巴结的AUC为0.853,灵敏度80.0%、特异度94.8%、准确率93.5%;验证集相应为71.4%、99.4%、98.4%。结论认为排除钙化淋巴结后RImax>6%对N分期诊断效能最佳。

要点

  • 测试集276个非钙化淋巴结站中,视觉分析灵敏度32.0%、特异度96.8%、准确率90.9%。
  • RImax以6%为最佳截断值,测试集AUC 0.853(P<0.001),灵敏度80.0%、特异度94.8%、准确率93.5%。
  • 验证集179个非钙化淋巴结站中,RImax截断值6%的灵敏度71.4%、特异度99.4%、准确率98.4%。

核心结论

  • 排除钙化淋巴结后,双时间点18F-FDG PET/CT应用RImax且截断值大于6%时,对食管癌淋巴结分期取得最佳诊断效能。

研究设计与样本

  • 测试集35例接受手术且未行新辅助化疗的食管鳞状细胞癌患者,验证集19例患者。
  • 双时间点PET/CT扫描于18F-FDG给药后60分钟和120分钟各采集一次。
  • 进行视觉分析及半定量分析,参数包括SUVmax、SUVpeak、基于SUVmax的滞留指数(RImax)和基于SUVpeak的滞留指数(RIpeak)。

主要发现

  • 原发食管病灶在各时间点扫描的SUVmax差异有统计学意义(ANOVA,P<0.001)。
  • 测试集276个非钙化淋巴结站中,视觉分析灵敏度32.0%(8/25)、特异度96.8%(243/251)、准确率90.9%(251/276)。
  • 测试集ROC分析显示RImax以6%为最佳截断值时AUC最大(AUC 0.853,P<0.001),灵敏度80.0%(20/25)、特异度94.8%(238/251)、准确率93.5%(258/276)。
  • 验证集179个非钙化淋巴结站中,RImax截断值6%的灵敏度71.4%(5/7)、特异度99.4%(171/172)、准确率98.4%(176/179)。
  • 验证集视觉分析灵敏度14.3%(1/7)、特异度98.8%(170/172)、准确率95.5%(171/179)。

关键数值与推荐

  • RImax最佳截断值为6%,用于检测转移性淋巴结。
  • 测试集RImax截断值6%的AUC为0.853(P<0.001)。
  • N分期评估仅纳入非钙化淋巴结站,排除钙化淋巴结。

临床怎么用

  • 作者认为,对拟手术的食管癌患者,采用双时间点18F-FDG PET/CT诊断流程可实现最佳临床管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The purpose of this study is to investigate the role of dual time point (DTP) 18F-FDG PET/CT in the staging of oesophageal cancer, especially in lymph node metastasis. METHODS: A total of 35 patients with oesophageal squamous cell carcinoma who underwent surgical treatment without neoadjuvant chemotherapy were enrolled as a test set and another 19 patients were enrolled as a validation set. The DTP PET/CT scans were obtained in dual time points at 60 and 120 min each, following the administration of 18F-FDG. Visual analysis was performed and semiquantitative analysis was performed using several PET parameters such as maximal standardized uptake values (SUVmax), peak SUV (SUVpeak) and retention indexes using SUVmax (RImax) and SUVpeak (RIpeak). RESULTS: Primary oesophageal lesions exhibited a significant difference for SUVmax at each time point scan (ANOVA, p < 0.001). For nodal staging, a total of 276 non-calcified nodal stations of the test set were evaluated. Sensitivity, specificity and accuracy of visual analysis were 32.0% (8 of 25), 96.8% (243 of 251) and 90.9% (251 of 276) in the test set. Using ROC analysis, RImax had the largest area under the curve (AUC) to detect metastatic lymphadenopathy at the optimal cut-off value of 6% (AUC 0.853, P < 0.001) in the test set (sensitivity, specificity and accuracy; 80.0% (20 of 25), 94.8% (238 of 251) and 93.5% (258 of 276)). In the validation set (179 non-calcified nodal stations), sensitivity, specificity and accuracy of RImax at the optimal cut-off of 6% were 71.4% (5 of 7), 99.4% (171 of 172) and 98.4% (176 of 179), whereas those of visual analysis were 14.3% (1 of 7), 98.8% (170 of 172) and 95.5% (171 of 179). CONCLUSIONS: The best diagnostic performance of nodal staging in patients with oesophageal cancer was achieved by application of RImax with a cut-off of more than 6% on DTP 18F-FDG PET/CT with the exclusion of calcified lymph nodes. Optimal clinical management in surgically-candidate oesophageal cancer patients could be achieved using the diagnostic flow on DTP 18F-FDG PET/CT.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Park S, Paeng JC, Kang CH, et al. Dual-time point 18F-FDG PET/CT for the staging of oesophageal cancer: the best diagnostic performance by retention index for N-staging in non-calcified lymph nodes. Eur J Nucl Med Mol Imaging. 2018. PMID: 29502309. doi:10.1007/s00259-018-3981-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。